title: Words of wisdom. Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.
authors.affiliation: Department of Urology, Kantonsspital, St. Gallen, Switzerland. hans-peter.schmid@kssg.ch
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Schmid
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Engeler